Nippon Pharmaceutical to Issue IPO, Appoints Nabil Investment Banking as Sales Manager
Nippon Pharmaceutical Ltd, located in Biratnagar, Morang, is set to issue an IPO. The company has appointed Nabil Investment Banking Ltd as the issue and sales manager.
Kathmandu. Nippon Pharmaceutical Ltd, located in Biratnagar Metropolitan City Ward No. 12, Bakari, Morang district, Koshi Province, is going to issue an IPO. The company has appointed Nabil Investment Banking Ltd as the share issue and sales manager for the said share issuance.
The agreement letter between the issuing company was signed by Mantu Ghimire, Managing Director of Nippon Pharmaceutical Ltd, on behalf of the company, and Manish Narayan Joshi, Chief Executive Officer of Nabil Investment Banking Ltd, on behalf of the bank.
Nippon Pharmaceutical Ltd is a certified pharmaceutical company that produces various types of medicines in accordance with WHO-GMP and international quality standards. The company manufactures the following products:
- Tablets
- Capsules
- Liquid medicines
- Ointments, cream gels
- ORS
- Dry syrups
- Penicillin
The company was duly registered in 2006 and the industry was established in 2017. It has been addressing the Nepali pharma market by developing and manufacturing a diverse product portfolio of high-quality medicines and pharmaceutical products. Nippon Pharmaceutical, which started its commercial production and marketing 5 years after establishment, i.e., from 2022, has been able to market more than 60 products across various therapeutic segments within 4 years of establishment.